C
Cynerio
Develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats
About Cynerio
Cynerio operates in the healthcare cybersecurity market, focusing on securing Internet of Medical Things (IoMT) and other IoT devices used in healthcare settings. The company provides automated security solutions that identify, protect, and manage risks associated with these devices. Cynerio's primary clients are healthcare organizations, including small and rural hospitals, which are particularly vulnerable to cyber threats like ransomware attacks. The business model revolves around offering a cybersecurity platform that integrates IoT attack visibility with IT security enforcement, enabling healthcare providers to respond effectively to cyber threats without disrupting patient care. Cynerio generates revenue through subscription-based services and customized security solutions tailored to the specific needs of healthcare institutions. The company's solutions ensure patient safety, data confidentiality, and operational continuity by addressing critical vulnerabilities in IoMT and IoT devices.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2017
- Headquarters
- New York City, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 60.8/100
- Industry
- Health, Security
- Sub-industry
- Health Platform, Data protection, Device security & Antivirus
- Sector
- Health Tech & Medtech, Network Security, Patient Care, Cybersecurity, Hard Tech, Health It
- Technology
- IoT InternetOfThings
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jul 2025 | $0 | — | Axonius | ↗ |
| SERIES B✓Equity / VC | May 2021 | $30M | $120M | MTIP · Rafael Development Corporation · Consensus Business Group · Accelmed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Cynerio is 770 monthly website visits, down 86.5% over the last three months. Cynerio's team declined 30% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
MTIP
Rafael Development Corporation
Accelmed
Series A2 investors entered at this stage
Consensus Business Group
ALIVE Israel HealthTech Fund
Other known investors3 additional known investors
Axonius
Elron Ventures
Royi benyossef
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cynerio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cynerio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.